| Patents for A61P 19 - Drugs for skeletal disorders (81,981) |
|---|
| 01/04/2006 | EP1397153A4 Methods for protecting allogeneic islet transplant using soluble ctla4 mutant molecules |
| 01/04/2006 | EP1311677B1 Regulation of human p2y1-like g protein-coupled receptor |
| 01/04/2006 | EP1307573B1 Adenoviral vectors for the transduction of chondrocytes |
| 01/04/2006 | EP1284754B1 Gel-like pharmaceutical composition for subcutaneous administration comprising bisphosphonic acids or their salts |
| 01/04/2006 | EP1250422B1 Myeloid colony stimulating factor and uses thereof |
| 01/04/2006 | EP1242403B1 2,4-diaminopyrimidine compounds usful as immunosuppressants |
| 01/04/2006 | EP1169298B1 Pharmaceutical compounds |
| 01/04/2006 | EP1149116B1 Process for the production of multiple cross-linked hyaluronic acid derivatives |
| 01/04/2006 | EP1102755B1 Substituted isoxazole derivatives as estrogen receptor modulators |
| 01/04/2006 | EP1083898B1 Novel use of hiv protease inhibiting compounds |
| 01/04/2006 | CN1717228A Pharmaceutical composition comprising a LTB4 antagonist and a cox-2 inhibitor or a combined cox1/2 inhibitor |
| 01/04/2006 | CN1714861A Thymus penta peptide slow releasing micro ball and its preparing method |
| 01/04/2006 | CN1714856A Chinese medicine composition for treating rheumatoid arthritis and its preparing method |
| 01/04/2006 | CN1714852A Medicine for treating various fracture and bone injury |
| 01/04/2006 | CN1714846A Health medicinal wine for traumatic injury |
| 01/04/2006 | CN1714799A Medicinal composition and its use in treating osteoarthritis |
| 01/04/2006 | CN1714787A Tromethamine gel form medicinal composition |
| 01/04/2006 | CN1234707C Anti-cancer chemicals of methotrexate derivatives and their uses in pharmaceutical science |
| 01/04/2006 | CN1234705C New hydroxyl indoles, their use as phosphor diesterase 4 inhibitors and method for producing same |
| 01/04/2006 | CN1234693C Indazol compound for inhibiting protein kinase and medicine composition and their application |
| 01/04/2006 | CN1234688C 3-arylindole and their use as cb2 receptor agonists |
| 01/04/2006 | CN1234417C Pharmaceutical compositions comprising dendritic cells for immunotherapy of automimmune disease and treatment methods using the same |
| 01/04/2006 | CN1234402C Method for treating bone fracture |
| 01/04/2006 | CN1234401C Bi-ant contained dampness dispelling and collaterals dredging medicinal capsule |
| 01/04/2006 | CN1234391C Spine osteopathy liquid |
| 01/04/2006 | CN1234385C Health-care medicinal plaster used for preventing and curing discopathy, osteosis, ischialgia |
| 01/04/2006 | CN1234380C Fracture setting medicine powder and its preparing process |
| 01/04/2006 | CN1234378C Chinese medicine for treating bone fracture and its preparing method |
| 01/04/2006 | CN1234375C Method for extracting active arthritis resisting element from Capparis fruit |
| 01/04/2006 | CN1234371C Application of nano copper powder for preparing medicine for prophylaxis of osteoporosis and bone fracture |
| 01/03/2006 | US6982286 Bicarbocyclic hydrazine/hydrazide compounds as inhibitors of semicarbazide-sensitive amine oxidases (SSAO), treat an inflammatory disease or condition, a disease related to carbohydrate metabolism, smooth muscle cell function |
| 01/03/2006 | US6982272 E.g., 4-acetylamino-N-(1-((4-cyano-1-methylpiperidin-4-yl-carbamoyl)-2 -(cyclohexylethyl)benzamide; Alzheimer's, auto-immune and Crohn's diseases; atherosclerosis; antiarthritic agents; osteoporosis; atherosclerosis |
| 01/03/2006 | US6982270 1-Phenyl-2-oxo-3,4-dihydro-6-phenylaminoquinazoline for example; cytokine suppressive anti-inflammatory drugs; combination therapy |
| 01/03/2006 | US6982263 Peptidyl carbamates; treatments for osteoporosis and autoimmune diseases |
| 01/03/2006 | US6982259 N-heterocyclic derivatives as NOS inhibitors |
| 01/03/2006 | US6982258 Low-calcemic oxime analogs of 1α,25-dihydroxy vitamin D3 |
| 01/03/2006 | US6982253 Liquid formulation of decitabine and use of the same |
| 01/03/2006 | CA2345818C Process for the preparation of oral pharmaceutical compositions comprising biphosphonates |
| 01/03/2006 | CA2343236C 4,4-biarylpiperidine derivatives |
| 12/29/2005 | WO2005123767A1 Peptide-based compounds |
| 12/29/2005 | WO2005123745A1 Tricyclic compounds |
| 12/29/2005 | WO2005123191A1 Pyk2 inhibitors for stimulation of osteoblast function |
| 12/29/2005 | WO2005123065A1 Chemokine receptor antagonistic medicinal composition |
| 12/29/2005 | WO2005053661A3 Pharmaceutical combinations |
| 12/29/2005 | WO2003012122A3 Crystallized structure of type iv collagen nc1 domain hexamer |
| 12/29/2005 | US20050289660 Cyclic amp phosphodiesterase 4d7 isoforms and methods of use |
| 12/29/2005 | US20050289658 System for regulating in vivo the expression of a transgene by conditional inhibition |
| 12/29/2005 | US20050288501 Reducing a 2-(protected amino)-3-(piperazin-1-yl, N-morpholinyl, or N-thiomorpholinyl) propanoate, deprotecting the amine, and reacting with t-butylisothiocyanate |
| 12/29/2005 | US20050288487 Human mast cell-expressed membrane proteins |
| 12/29/2005 | US20050288368 Compositions and methods for treating and preventing necrosis |
| 12/29/2005 | US20050288363 Therapeutic compositions and methods of use |
| 12/29/2005 | US20050288357 e.g. 4-(2-{2-[4-hydroxy-4-(1-propylcyclobutyl)but-1-enyl]-5-oxopyrrolidin-1-yl}ethyl)benzoic acid; antiinflammatory, hypotensive, antiulcer agent |
| 12/29/2005 | US20050288356 Derivatives of indole-3-carboxamide, preparation method thereof and application of same in therapeutics |
| 12/29/2005 | US20050288353 Methods of modulating c-kit tyrosine protein kinase function with indolinone compounds |
| 12/29/2005 | US20050288340 Substituted heteroaryl- and phenylsulfamoyl compounds |
| 12/29/2005 | US20050288337 Novel compounds |
| 12/29/2005 | US20050288325 Therapy for andropause using estrogen agonists/antagonists and testosterone |
| 12/29/2005 | US20050288312 Bicyclic pyridine and pyrimidine p38 kinase inhibitors |
| 12/29/2005 | US20050288311 2-(dipropylamino)-8-(4-thiomorpholinyl)pyrido[3,4-d]pyrimidin-4(3H)-one; kianses inhibitor; anticarcinlgenic, antidiabetic, antiinflammatory, hypotensive agent; nontoxic |
| 12/29/2005 | US20050288305 N-biarylmethyl aminocycloalkanecarboxamide derivatives |
| 12/29/2005 | US20050288303 Cyclic protein tyrosine kinase inhibitors |
| 12/29/2005 | US20050288285 Substituted 3-amino-thieno[2,3-b]pyridine-2-carboxylic acid amide compounds and processes for preparing and their uses |
| 12/29/2005 | US20050288254 Treating sepsis or septic shock by administering 1-stearoyl, 1-palmitoyl-, 1-myristoyl- lysophosphatidylcholine, or 1-oleoyllysophosphatidylcholine or sphingosylphosphorylcholine. |
| 12/29/2005 | US20050288252 Composition for stimulating bone growth and differentiation and method for isolating same |
| 12/29/2005 | US20050288230 Non-steroidal anti-androgen therapy |
| 12/29/2005 | US20050288229 Bone and/or cartilage development-stimulating peptide incorporating proline or hydroxyproline; implants |
| 12/29/2005 | US20050288219 Osteoprotegerin in milk |
| 12/29/2005 | US20050288211 Chemokine inhibitors; for treatment of gout; for inhibiting migration of neutrophils involved in pathogenesis |
| 12/29/2005 | US20050287617 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same |
| 12/29/2005 | US20050287603 Modulation of bone development |
| 12/29/2005 | US20050287546 Novel proteases |
| 12/29/2005 | US20050287195 Transdermal drug delivery systems |
| 12/29/2005 | US20050287160 Useful for treatment and prevention of prostate cancer, especially when associated with bone metastases; also a cytotoxic T lymphocyte that specifically recognizes complex of HLA-A24 antigen and the cancer antigen peptide |
| 12/29/2005 | US20050287144 For the modulation of signal activities controlled by NF-kappa B-inducing kinase (NIK); cancer , rheumatoid arthritis, osteoarthritis, inflammatory bowel disease, asthma, cardiac infarct, Alzheimer's disease, or atherosclerosis |
| 12/29/2005 | US20050287142 Remedies or preventives for rheumatoid arthritis |
| 12/29/2005 | US20050287135 Injectable solid hyaluronic acid carriers for delivery of osteogenic proteins |
| 12/29/2005 | DE102004045187A1 Wirkstoff, der in der Lage ist, die Überführung von inaktivem TGFb-latent in aktiven TGFb zu induzieren Agent that is capable of inducing the conversion of inactive latent TGFb-in active TGFb |
| 12/29/2005 | CA2571482A1 Pyk2 inhibitors for stimulation of osteoblast function |
| 12/29/2005 | CA2568601A1 Peptide-based compounds |
| 12/28/2005 | EP1609863A2 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 12/28/2005 | EP1609798A1 Fused heterocyclic derivative, medicinal composition containing the same, and medicinal use thereof |
| 12/28/2005 | EP1609797A1 Compound having affinity with calcified tissue |
| 12/28/2005 | EP1609781A1 Optical resolution of (1-benzyl-4-methylpiperidin-3-yl)-methylamine |
| 12/28/2005 | EP1609475A1 Remedy or preventive for low turnover bone diseases |
| 12/28/2005 | EP1609469A2 Compositions and methods for stimulating bone growth |
| 12/28/2005 | EP1608399A2 Ligands for tgf--beta binding proteins and uses thereof |
| 12/28/2005 | EP1608363A1 Methods for treating inflammatory conditions or inhibiting jnk |
| 12/28/2005 | EP1527076B1 Dihydro-dibenzo[b,e]oxepine based selective estrogen receptor modulators, compositions and methods |
| 12/28/2005 | EP1470124B1 2-(PYRIDIN-2-YLAMINO)-PYRIDO 2,3-d]PYRIMIDIN-7-ONES |
| 12/28/2005 | EP1432450B1 Therapeutically useful triethyleneglycol cholesteryl oligonucleotides |
| 12/28/2005 | EP1382604B1 Quinoline derivative having azolyl group and quinazoline derivative |
| 12/28/2005 | EP1377593B1 2-amino-propanol derivatives |
| 12/28/2005 | EP1367060B1 Glucopyranosyloxybenzylbenzene derivatives and medicinal use thereof |
| 12/28/2005 | EP1224183B1 Heterocyclic sodium/proton exchange inhibitors and method |
| 12/28/2005 | EP1129089B1 Spiro-indolines as y5 receptor antagonists |
| 12/28/2005 | EP1124810B9 2-amino-thiazole derivatives, process for their preparation, and their use as antitumor agents |
| 12/28/2005 | EP1117411B1 Process for the preparation of oral pharmaceutical compositions comprising biphosphonates |
| 12/28/2005 | EP1117410B1 Use of bisphosphonic acid derivatives for preparing a medicine for treating lameness |
| 12/28/2005 | EP0994093B1 Polyhydroxyphenol derivatives and preventive and therapeutic agents for bone and cartilage diseases containing the same |
| 12/28/2005 | EP0991660B1 DEUTERATED and undeuterated CYCLOSPORINE ANALOGS AND THEIR USE AS IMMUNOMODULATING AGENTS |